Fundraising FoxKolon TissueGene
Rockville, US · Delaware corporation
Find your way into Kolon TissueGene
Sign up to see every warm intro you have to Kolon TissueGene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kolon TissueGene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CS
Charles Stephen NyeNamed on SEC filing
SJ
Sun Jin KimNamed on SEC filing
YJ
Yonggyun JeongNamed on SEC filing
SS
Sung Su HanNamed on SEC filing
GY
Gun Young ParkNamed on SEC filing
MJ
Moon Jong NohNamed on SEC filing
JI
Jung In KimNamed on SEC filing
SK
Soon-Wook KweonNamed on SEC filing
DH
Diana HalimNamed on SEC filing
SJ
Sun Joo LeeNamed on SEC filing
YJ
Young Joon KimNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$124.7M disclosed across 4 rounds · 2021–2024
▶$35MraisedJun 2024 · 1 investors · BiotechnologyRule 506(b)
▶$35MraisedJun 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Soon-Wook KweonExecutive Officer
- Yonggyun JeongExecutive Officer
- Gun Young ParkExecutive Officer
- Sun Jin KimExecutive Officer
- Jung In KimExecutive Officer, Director
- Sun Joo LeeDirector
- Charles NyeExecutive Officer
- Young Joon KimExecutive Officer
- Diana HalimExecutive Officer
- Moon Jong NohExecutive Officer, Director
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedMay 2023 · 1 investors · BiotechnologyRule 506(b)
▶$30MraisedMay 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles Stephen NyeExecutive Officer
- Sun Jin KimExecutive Officer
- Yonggyun JeongExecutive Officer
- Sung Su HanExecutive Officer, Director
- Gun Young ParkExecutive Officer
- Moon Jong NohExecutive Officer, Director
- Jung In KimExecutive Officer, Director
- Soon-Wook KweonExecutive Officer
- Diana HalimExecutive Officer
- Sun Joo LeeDirector
- Young Joon KimExecutive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.6MraisedAug 2022 · 2 investors · BiotechnologyRule 506(b)
▶$29.6MraisedAug 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jangik LeeDirector
- Charles Stephen NyeExecutive Officer
- Young Joon KimExecutive Officer
- Moon Jong NohExecutive Officer, Director
- Sun Jin KimExecutive Officer
- Sung Su HanExecutive Officer, Director
- Soon-Wook KweonExecutive Officer
- Yonggyun JeongExecutive Officer
- Jung In KimExecutive Officer, Director
- Offering amount
- $29.6M
- Amount sold
- $29.6M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.1MraisedDec 2021 · 2 investors · BiotechnologyRule 506(b)
▶$30.1MraisedDec 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sun Jin KimExecutive Officer
- Yonggyun JeongExecutive Officer
- Young Joon KimExecutive Officer
- Jangik LeeDirector
- Min Seok KimExecutive Officer, Director
- Moon Jong NohExecutive Officer, Director
- Sung Su HanExecutive Officer, Director
- Charles Stephen NyeExecutive Officer
- Soon-Wook KweonExecutive Officer
- Offering amount
- $30.1M
- Amount sold
- $30.1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Kolon TissueGene raised?
- Kolon TissueGene has disclosed $124.7M raised across 4 rounds.
- Where is Kolon TissueGene headquartered?
- Kolon TissueGene is headquartered in Rockville, US.